Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Stock indices matter because they summarize broad market performance, guide diversification, and influence risk assessments for investors.
27,507 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Silver miners surged 124% over the past year and platinum climbed 89%, but volatility has risen. Investors face a cle...
Quantum computing stocks moved lower in Monday trading as investors rotated into safer assets amid a broader tech mar...
Vanguard's consumer staples ETF outperforms a sagging broader market, underscoring the pull of essential goods during...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...
Geopolitical tensions and stubborn inflation are rattling markets. Even higher-income americans turning cautious sign...
As the IoT market expands, Synaptics is recalibrating its business to capture devices beyond smartphones. This deep d...
DoorDash is down about 30% year-to-date as Amazon climbs about 14%, illustrating a widening gap between pure-delivery...
Beam Global is shaping the clean-energy charging space. In this piece, we break down what Q1 2026 earnings might reve...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Investors chased space-focused stocks higher on SpaceX IPO speculation, lifting Spacemobile 20%, Planet Labs 15%, and...
Uber's CFO argues AI will reduce future hiring needs more than it boosts output, signaling tougher labor-market dynam...